Associate Program Director, BMT
Dr. Dalovisio is a native of New Orleans, Louisiana. He attended Jesuit High School and Washington & Lee University. He received a Doctor of Medicine degree from Louisiana State University Health Sciences Center in Shreveport, Louisiana. He completed an Internal Medicine Residency followed by a Hematology/Oncology Fellowship at Rush University Medical Center in Chicago, Illinois. Dr. Dalovisio is a member of the American Society of Hematology, American Society of Blood and Marrow Transplantation, and American Society of Clinical Oncology.
Dr. Dalovisio's professional interests include hematologic malignancies and stem cell transplant. He serves as interim head for the section of Hematology and Stem Cell Transplant, and the Co-Director of Adolescent and Young Adult Oncology Program. He currently practices at The Gayle and Tom Benson Cancer Center on the main campus of Ochsner Medical Center.
Blackburn PR, Huang L, Dalovisio A, Pitel BA, Chen D, Oliveira JL, Wood AJ, Smadbeck JB, Johnson SH, Vasmatzis G, Haferlach C, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Peterson JF. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion. Cancer Genet. 2020 Feb;241:67-71. doi: 10.1016/j.cancergen.2019.12.005. Epub 2019 Dec 26.
Finn L, Dalovisio A, Foran J. Older patients with acute myeloid leukemia: treatment challenges and future directions. Ochsner J. 2017 Winter;17(4):398-404.